JapanStake
Services · Fiscal year end Mar 31

KNC Laboratories Co., Ltd.

6568

神戸天然物化学株式会社

FIGI BBG0016Y86S46568.T6568 JPCorp. no. 3140001022497

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥3.4 billion (+1.6% YoY), Ordinary income ¥0 billion (-86.9% YoY), Net income ¥0 billion (-98.1% YoY).

This periodYear on year
Revenue¥3.4bn+1.6%
Ordinary profit¥11m-86.9%
Net profit to owners¥1m-98.1%

From the securities report on EDINET, which states no forecast. History via /v1/companies/6568/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2026-03-31
Revenue
¥9.1bn
Net income
¥766m
ROE
5.6%
Equity ratio
65.1%
Dividend / share
¥33
Employees
340
Revenue · ¥bn
FY2022: ¥7.4bn 7.44 FY2022FY2023: ¥8.6bn 8.63 FY2023FY2024: ¥9.2bn 9.15 FY2024FY2025: ¥8.2bn 8.18 FY2025FY2026: ¥9.1bn 9.09 FY2026
Net income · ¥bn
FY2022: ¥0.6bn 0.64 FY2022FY2023: ¥1.5bn 1.54 FY2023FY2024: ¥1.5bn 1.49 FY2024FY2025: ¥0.7bn 0.74 FY2025FY2026: ¥0.8bn 0.77 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥9.1bn¥0.8bn¥21.6bn¥14.1bn5.6%¥99.02¥2.3bn
2025-03-31¥8.2bn¥0.7bn¥20.2bn¥13.5bn5.5%¥95.42¥1.5bn
2024-03-31¥9.2bn¥1.5bn¥18.6bn¥13.1bn12.0%¥193.5¥3.2bn
2023-03-31¥8.6bn¥1.5bn¥15.4bn¥11.7bn13.8%¥200.06¥2.0bn
2022-03-31¥7.4bn¥0.6bn¥14.0bn¥10.6bn6.2%¥82.78¥0.6bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %5.628.8
Ordinary margin0.113173.2
Equity ratio, %65.166.2
Revenue growth0.111872.3
Net income growth0.039239.8
Operating cash flow / assets0.104575.1
Policy-uncertainty measure0.51 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 1 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 0.0% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥3.6bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥18m, 0.8% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/6568/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Share buyback, report to —: ¥152m acquired of a ¥152m limit. /v1/companies/6568/buybacks
Internal control, 2026-06-23: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-24 · 剰余金処分の件 · passed. /v1/companies/6568/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2022-05-16 – 2025-10-17-100,000−1.29pt¥1,115¥1,115–1,115
公益財団法人KNC広瀬財団2025-10-17 – 2025-10-1700.00pt——
individual filer2022-03-23 – 2025-06-2400.00pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/6568/trades.

5% filings

Large shareholding reports on 6568
FiledFilerStakeChangeStated purpose
2026-10-06SBI SECURITIES Co., Ltd.5.05%——
2026-03-23SBI SECURITIES Co., Ltd.3.16%−2.40pt—
2025-10-23KNC Kosan Co.,Ltd.39.18%−2.20pt—
2025-10-23KNC Kosan Co., Ltd.37.73%−1.45pt—
2025-10-23individual filer37.73%−1.45pt—
2025-10-23individual filer28.73%−9.00pt—
2025-10-20KNC HIROSE FOUNDATION9.00%——
2025-06-26individual filer10.45%−0.21pt—
2025-06-20SBI SECURITIES Co., Ltd.5.56%+0.03pt—
2025-04-07SBI SECURITIES Co., Ltd.5.53%+0.37pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
6 issues
Book value
¥288m
Sold in the year
— — issues
Bought in the year
¥4m 3 issues
Mutual, both reports
0
Held by listed cos.
0
HoldsBook valueShares vs. prior yearMutual
Tri Chemical Laboratories Inc. 4369¥117m+1.4%no
ONO PHARMACEUTICAL CO., LTD. 4528¥63m0.0%no
KURARAY CO.,LTD. 3405¥61m+3.8%no
J-Pharma Co.,Ltd. 520A¥27m—no
The San-in Godo Bank,Ltd. 8381¥17m0.0%no
Sumitomo Mitsui Financial Group, Inc. 8316¥3m0.0%no

Purposes, all holdings and mutual flags via /v1/companies/6568/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
KNC興産(株)1,512,00019.53%
individual holder813,00010.50%
individual holder723,5009.35%
(公財)KNC広瀬財団700,0009.04%
individual holder240,0003.10%
individual holder221,1002.86%
individual holder158,2002.04%
individual holder122,0001.58%
individual holder103,2001.33%
神戸天然物化学従業員持株会97,3001.26%

Get this as JSON

GET /v1/companies/6568
GET /v1/companies/6568/financials
GET /v1/companies/6568/details
GET /v1/companies/6568/segments
GET /v1/companies/6568/voting
GET /v1/companies/6568/tender-offers
GET /v1/companies/6568/indicators
GET /v1/companies/6568/earnings-releases
GET /v1/events?ticker=6568
GET /v1/companies/6568/trades         
GET /v1/companies/6568/cross-holdings 
GET /v1/companies/6568/brief          

Plans from $9 a month · Documentation